Age is a predictor of efficacy of monoclonal antibodies in allergic severe asthma

M. D'Amato (Naples, Italy), F. Simioli (Naples, Italy), M. Martino (Naples, Italy), M. Porzio (Naples, Italy), A. Stanziola (Naples, Italy), A. Molino (Naples, Italy)

Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. D'Amato (Naples, Italy), F. Simioli (Naples, Italy), M. Martino (Naples, Italy), M. Porzio (Naples, Italy), A. Stanziola (Naples, Italy), A. Molino (Naples, Italy). Age is a predictor of efficacy of monoclonal antibodies in allergic severe asthma. 4386

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: